-
STFS
Development of Severe Fever with Thrombocytopenia Syndrome (SFTS) vaccines
- Candidate verification → Non clinical trial → Phase 1 → Phase 2
-
Norovirus gastroenteritis
Development of multivalent VLP (virus-like particle) vaccines
- Candidate verification → (TRL4) → Non clinical trial → Phase 1 → Phase 2
-
Next-generation Tuberculosis
Development of boosting vaccines to enhance the efficacy of the BCG vaccine
- Candidate verification → Non clinical trial → Phase 1 → Phase 2
-
Hand-Foot-and-Mouth Disease
Establishment of protective immune indicators for HFMD vaccines and the completion of clinical trials
- Non clinical trial → Phase 1 → Phase 2
-
Universal Influenza
Development of broad-spectrum influenza vaccines to combat both seasonal and pandemic influenza
- Candidate verification → Non clinical trial → Phase 1
-
Dengue Fever
Development of safe and effective vaccines
- Candidate verification → Non clinical trial
-
Respiratory Syncytial Virus
Development of RSV vaccines by rational design of recombinant antigens
- Candidate verification → Non clinical trial
-
Vaccine platform technologies for emerging viral diseases
Establish technical platforms amenable to rapid response to future pandemics
- Bacterial production of low-cost vaccine candidates
Development of a communal platform technologies for both NIP and unmet needs vaccines
- VLP(Virus-Like Particle)/NP(Nanoparticle) vaccines
- Novel inactivated viral vaccine platform
- Live attenuated vaccine platform for cross-protection